The Workers Left Out of Trump’s Drug-Manufacturing Renaissancenews2025-11-04T10:00:29+00:00November 4th, 2025|The New York Times|
Why Medicare Recipients Should Check Their 2026 Drug Plans Nownews2025-11-01T09:00:46+00:00November 1st, 2025|The New York Times|
F.D.A. Moves to Speed Approvals for Cheaper Copycat Drugsnews2025-10-29T20:07:07+00:00October 29th, 2025|The New York Times|
Drug With a 30-Year Monopoly Is Target of State-Level Push to Curb Pricesnews2025-10-23T09:00:45+00:00October 23rd, 2025|The New York Times|
How TrumpRx Website May Affect Your Drug Costs After Pfizer Dealnews2025-10-01T22:15:18+00:00October 1st, 2025|The New York Times|
F.D.A.’s Approval of a Drug for Autism Upends Review Processnews2025-09-23T23:09:46+00:00September 23rd, 2025|The New York Times|
Where U.S. Medicines Are Made and How Trump’s Tariffs Could Affect Themnews2025-08-24T03:39:58+00:00August 24th, 2025|The New York Times|
Trump’s Tariff Threat for Drug imports Poses Big Political Risksnews2025-04-15T14:33:12+00:00April 15th, 2025|The New York Times|
Trump’s Next Tariffs Target Could be Foreign-Made Pharmaceuticalsnews2025-04-04T09:00:28+00:00April 4th, 2025|The New York Times|
FDA Layoffs Could Raise Drug Costs and Erode Food Safetynews2025-04-04T01:59:02+00:00April 4th, 2025|The New York Times|
